Ann Pediatr Endocrinol Metab.  2013 Mar;18(1):1-8. 10.6065/apem.2013.18.1.1.

The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice

• Lim JS

• KMID: 1429671
• DOI: http://doi.org/10.6065/apem.2013.18.1.1

Abstract

Cardiovascular disease (CVD) is a leading cause of death worldwide including Korea. The risk factors of CVD are known as positive family history of early CVD, obesity, hypertension, diabetes, and dyslipidemia. Among those, dyslipidemia is one of modifiable risk factors. Dyslipidemia starts in childhood and progress to adulthood. Furthermore, dyslipidemia cause atherosclerosis and is closely related to other CVD risks. On the rationale that early identification and control of pediatric dyslipidemia will reduce the risk and severity of CVD in adulthood, the National Heart, Lung, and Blood Institute guidelines expanded to universal screening for lipid levels. However, there was no guideline for lipid screening and management in Korean children and adolescents yet. This review deals with the rationale of early identification and control of pediatric dyslipidemia along with the current Korean status of pediatric dyslipidemia. This review also deals with how to screen, diagnosis, and treatment of pediatric dyslipidemia.

Keyword

Dyslipidemia; Children; Adolescents; Screening; Management

MeSH Terms

Adolescent
Atherosclerosis
Cardiovascular Diseases
Cause of Death
Child
Collodion
Dyslipidemias
Humans
Hypertension
Korea
Mass Screening
National Heart, Lung, and Blood Institute (U.S.)
Obesity
Risk Factors
Collodion